Product Images Losartan Potassium

Losartan Potassium is a medication available in the form of tablets, with each tablet containing 25mg of the active ingredient. There are 45 tablets in each package, as indicated by the product code NOC# TI6IDO0ES 45.*

This appears to be a chart or graph representing the results of a study comparing the effectiveness of Atenolol versus Losartan Potassium in reducing the risk of a primary endpoint in patients. The chart shows the study month on the x-axis and the percentage of patients with the primary endpoint on the y-axis. It also includes information about the adjusted risk reduction of 13% with a p-value of 0.021.*

This appears to be a graph or chart related to a study on the effectiveness of two medications in reducing the risk of fatal or non-fatal strokes. The two medications are Atenolol and Losartan potassium. The chart shows a time frame of 66 months with the months labeled on the bottom axis. The adjusted risk reduction is 25% with a p-value of 0.00. No patients experienced a fatal or non-fatal stroke during the study.*

The text provides data from a study comparing the effects of Losartan K and atenolol on a composite stroke outcome including both fatal and non-fatal cases. The results of the study are presented in tables stratified by various factors including age, gender, race, diabetes status, and history of CVD. The symbols in the tables are proportional to the sample size. The data have been adjusted for baseline Framingham risk score and level of electrocardiographic left ventricular hypertrophy.*

This is a comparison of a drug called Losartan Potassium to a placebo in terms of risk reduction of an event. The risk reduction is 16.1% and the significance level is p=0.022. The number 401 and the word "patients" are present, indicating that this is a study involving a group of patients. There is not enough information to know what specific event is being measured.*